Comirnaty (2023-2024) PF (cvx 309) Interactions
There are 321 drugs known to interact with Comirnaty (2023-2024) PF (cvx 309) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)). Of the total drug interactions, 1 is major, 317 are moderate, and 3 are minor.
- View all 321 medications that may interact with Comirnaty (2023-2024) PF (cvx 309)
Most frequently checked interactions
View interaction reports for Comirnaty (2023-2024) PF (cvx 309) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)) and the medicines listed below.
- Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Afluria (influenza virus vaccine, inactivated)
- alfuzosin
- Allegra (fexofenadine)
- allopurinol
- amiodarone
- amlodipine
- amoxicillin / clavulanate
- Arexvy (rsv vaccine pref3, recombinant)
- Aspirin Low Strength (aspirin)
- atorvastatin
- azithromycin
- cephalexin
- clonazepam
- doxazosin
- Eliquis (apixaban)
- fluticasone
- Fluzone High-Dose Quadrivalent (influenza virus vaccine, inactivated)
- GlipiZIDE XL (glipizide)
- lisinopril
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- oxycodone
- pantoprazole
- potassium chloride
- prednisone
- Prevnar 13 (pneumococcal 13-valent vaccine)
- Shingrix (zoster vaccine, recombinant)
- tamsulosin
- Vitamin D3 (cholecalciferol)
Report options
QR code containing a link to this page
More about Comirnaty (2023-2024) PF (cvx 309) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309))
- Comirnaty (2023-2024) PF (cvx 309) consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
